Home › Asset managers › Compare 2024-2025 › BlackRock vs ProShares
BlackRock 2024-2025 · ProShares 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 8,258 | 7,560 | 520 | 178 | 93.6% | 92.8% |
| Board proposals | 7,109 | 6,611 | 367 | 131 | 94.7% | 94.1% |
| E&S shareholder proposals | 234 | 184 | 23 | 27 | 88.9% | 87.4% |
| Other items | 915 | 765 | 130 | 20 | 85.5% | 84.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
498 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | ProShares |
|---|---|---|---|---|---|---|
| SILENCE THERAPEUTICS PLC | June 26, 2025 | To re-appoint as a director Iain Ross, who retires in accordance with the articles of association. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| SILVERCREST ASSET MANAGEMENT GROUP INC. | June 4, 2025 | To amend our 2012 Equity Incentive Plan, as amended, to increase the authorized number of shares issuable under the plan by 1,500,000 shares. Compensation |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| SITE CENTERS CORP. | May 14, 2025 | Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 11 funds |
| SKYX PLATFORMS CORP. | July 10, 2024 | To approve the Company's Amended and Restated 2021 Stock Incentive Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 7 funds |
| SKYX PLATFORMS CORP. | July 10, 2024 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 7 funds |
| SL GREEN REALTY CORP. | June 3, 2025 | To approve our Sixth Amended and Restated 2005 Stock Option and Incentive Plan. Compensation |
Board | For | FOR 21 funds |
AGAINST 13 funds |
| SL GREEN REALTY CORP. | June 3, 2025 | To approve, on a non-binding advisory basis, our executive compensation. Say-on-Pay |
Board | For | FOR 34 funds |
AGAINST 13 funds |
| SLEEP NUMBER CORP. | May 28, 2025 | Approve Amendment to the Sleep Number Corporation 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 500,000 shares Compensation |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| SMARTFINANCIAL INC. | May 22, 2025 | To approve the SmartFinancial, Inc. Omnibus Incentive Plan. Compensation |
Board | For | FOR 9 funds |
AGAINST 8 funds |
| SOLARIS OILFIELD INFRASTRUCTURE INC. | August 30, 2024 | LTIP Amendment Proposal: To approve an amendment (the "LTIP Amendment") to the Company's Long Term Incentive Plan (the "LTIP") to increase the number of shares of Class A common stock, par value $0.01 per share, of the Company issuable under such plan (the "LTIP Amendment Proposal"). Compensation |
Board | For | FOR 10 funds |
AGAINST 7 funds |
| SPHERE ENTERTAINMENT CO. | December 9, 2024 | Approval of the Company's 2020 Employee Stock Plan, as amended. Compensation |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| SPIRIT AEROSYSTEMS HOLDINGS INC. | May 23, 2025 | Advisory vote to approve the compensation of named executive officers Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 1 fund |
| STANDARD BIOTOOLS INC. | June 18, 2025 | To approve an amendment to our Amended and Restated 2011 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 17,400,000 shares. Compensation |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| STEM INC. | June 4, 2025 | To approve an amendment and restatement of the Stem, Inc. 2024 Equity Incentive Plan to increase the number of shares available for issuance by 7,500,000 shares and to extend the plan term. Compensation |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| SUMMIT THERAPEUTICS INC. | June 12, 2025 | Approval, by a non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 11 funds |
| SUNRUN INC. | June 11, 2025 | Advisory proposal of the compensation of our named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 31 funds |
AGAINST 12 funds |
| SUPER MICRO COMPUTER INC. | June 4, 2025 | To approve the further amendment and restatement of the Super Micro Computer, Inc. 2020 Equity and Incentive Compensation Plan. Compensation |
Board | For | FOR 33 funds |
AGAINST 15 funds |
| SURGERY PARTNERS INC. | June 6, 2025 | Approval of the Surgery Partners, Inc. 2025 Omnibus Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 8 funds |
| SURGERY PARTNERS INC. | June 6, 2025 | Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 8 funds |
| SYMRISE AG | May 20, 2025 | REELECT BERND HIRSCH TO THE SUPERVISORY BOARD Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| SYNAPTICS INC. | October 29, 2024 | Proposal to approve the Company's amended and restated 2019 Equity and Incentive Compensation Plan. Compensation |
Board | For | FOR 22 funds |
AGAINST 17 funds |
| TANGO THERAPEUTICS INC. | June 5, 2025 | Election of Class I Director: Lesley Ann Calhoun Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 9 funds |
| TELADOC HEALTH INC. | May 22, 2025 | Approve an amendment to the Teladoc Health, Inc. 2023 Incentive Award Plan. Compensation |
Board | For | FOR 16 funds |
AGAINST 8 funds |
| TELADOC HEALTH INC. | May 22, 2025 | Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 8 funds |
| TERAWULF INC. | May 5, 2025 | The approval of an amendment to the 2021 Omnibus Incentive Compensation Plan to increase the number of available shares thereunder. Compensation |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| TEXAS CAPITAL BANCSHARES INC. | April 15, 2025 | To approve, on an advisory basis, the 2024 compensation of the Company's named executive officers as described in the Proxy Statement; Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 17 funds |
| TOWER SEMICONDUCTOR LTD | July 31, 2024 | ELECT AMIR ELSTEIN AS CHAIRMAN AND APPROVE HIS TERMS OF COMPENSATION (SUBJECT TO APPROVAL OF HIS ELECTION AS DIRECTOR UNDER PROPOSAL 1) Corporate Governance |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| TREDEGAR CORP. | May 8, 2025 | Non-Binding Advisory Vote to Approve Named Executive Officer Compensation Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 8 funds |
| TRIUMPH FINANCIAL INC. | April 22, 2025 | Approval of the Fourth Amendment to the Triumph Financial, Inc. 2014 Omnibus Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 15 funds |
| TRIUMPH FINANCIAL INC. | April 22, 2025 | Management Proposal Regarding Advisory Approval of the Company's Executive Compensation. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 15 funds |
| TRUIST FINANCIAL CORP. | April 29, 2025 | Advisory vote to approve Truist's executive compensation program. Say-on-Pay |
Board | For | FOR 57 funds |
AGAINST 17 funds |
| ULTRA CLEAN HOLDINGS INC. | May 21, 2025 | Approval, by an advisory vote, of the compensation of Ultra Clean Holdings, Inc.'s named executive officers for fiscal 2024 as disclosed in our proxy statement for the 2025 Annual Meeting of Stockholders. Say-on-Pay |
Board | For | FOR 27 funds |
AGAINST 12 funds |
| ULTRAGENYX PHARMACEUTICAL INC. | May 15, 2025 | Advisory (non-binding) vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 42 funds |
AGAINST 4 funds |
| ULTRAGENYX PHARMACEUTICAL INC. | May 15, 2025 | Approval of the Second Amended and Restated 2023 Incentive Plan. Compensation |
Board | For | FOR 27 funds |
AGAINST 4 funds |
| UNITED NATURAL FOODS INC. | December 17, 2024 | To approve the Fourth Amended and Restated 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 16 funds |
AGAINST 11 funds |
| UNITED PARKS & RESORTS INC. | June 13, 2025 | Approval of the United Parks & Resorts Inc., 2025 Omnibus Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| UNITEDHEALTH GROUP INC. | June 2, 2025 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 87 funds |
AGAINST 19 funds |
| UNIVERSAL HEALTH SERVICES INC. | May 14, 2025 | Election of Director: Maria R. Singer Director Elections |
Board | For | FOR 50 funds |
WITHHOLD 16 funds |
| UPSTART HOLDINGS INC. | May 23, 2025 | The approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 8 funds |
| USANA HEALTH SCIENCES INC. | May 19, 2025 | Approval of the USANA Health Sciences, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 13 funds |
AGAINST 11 funds |
| V.F. CORP. | July 23, 2024 | Vote to approve the amendment and restatement of the 1996 Stock Compensation Plan. Compensation |
Board | For | FOR 22 funds |
AGAINST 3 funds |
| VALERO ENE | May 6, 2025 | Advisory vote to approve the 2024 compensation of named executive officers. Say-on-Pay |
Board | Not determined | FOR 72 funds |
AGAINST 17 funds |
| VALHI INC. | May 22, 2025 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| VENTYX BIOSCIENCES INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 8 funds |
| VERACYTE INC. | June 17, 2025 | The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 16 funds |
AGAINST 11 funds |
| VERU INC. | March 13, 2025 | To amend the Veru Inc. 2018 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| VICTORY CAPITAL HOLDINGS INC. | October 11, 2024 | To amend Victory Capital's Second Amended and Restated Certificate of Incorporation to increase its authorized number of shares of preferred stock, par value $0.01 per share, to 100,000,000 (the "authorized preferred share increase proposal"). Capital Structure |
Board | For | FOR 16 funds |
AGAINST 7 funds |
| VIKING THERAPEUTICS INC | May 20, 2025 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 38 funds |
AGAINST 2 funds |
| VIPER ENERGY INC. | May 20, 2025 | The approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 43 funds |
AGAINST 7 funds |
| VIRGIN GALACTIC HOLDINGS INC. | June 5, 2025 | Approval of the Third Amended and Restated Virgin Galactic Holdings, Inc. 2019 Incentive Award Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| VIRGIN GALACTIC HOLDINGS INC. | June 5, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| VIRIDIAN THERAPEUTICS INC. | June 20, 2025 | To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 14 funds |
AGAINST 10 funds |
| VIRIDIAN THERAPEUTICS INC. | June 20, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 10 funds |
| VOYAGER THERAPEUTICS INC. | June 3, 2025 | To approve the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 9 funds |
| WARNER BROS. DISCOVERY INC. | June 2, 2025 | To vote on an advisory resolution to approve the 2024 compensation of Warner Bros. Discovery, Inc.'s named executive officers, commonly referred to as a "Say-on-Pay" vote. Say-on-Pay |
Board | For | FOR 60 funds |
AGAINST 23 funds |
| WAVE LIFE SCIENCES LTD. | August 6, 2024 | To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement Compensation |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| WAVE LIFE SCIENCES LTD. | August 6, 2024 | To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. Capital Structure |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| WHEELS UP EXPERIENCE INC. | June 10, 2025 | To approve an amendment to the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as previously amended by Amendment No. 1 thereto, the "Amended and Restated 2021 LTIP"), to increase the aggregate number of shares of the Company's Class A common stock, $0.0001 par value per share ("Common Stock"), available for awards made under the Amended and Restated 2021 LTIP and extend the termination date of such plan to March 26, 2035. Compensation |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| WHITESTONE REIT | May 15, 2025 | To approve an amendment to the 2018 Long-Term Equity Incentive Ownership Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 13 funds |
| WORKDAY INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 64 funds |
AGAINST 28 funds |
| WORTHINGTON ENTERPRISES INC. | September 24, 2024 | Approve the Worthington Enterprises, Inc. 2024 Long-Term Incentive Plan. Compensation |
Board | For | FOR 18 funds |
AGAINST 12 funds |
| X4 PHARMACEUTICALS INC. | June 9, 2025 | To hold a non-binding, advisory "say-on-pay" vote on the Company's executive compensation. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| XENCOR INC. | June 12, 2025 | To approve the proposed amendment and restatement of the Company's 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 3,000,000 shares. Compensation |
Board | For | FOR 20 funds |
AGAINST 16 funds |
| XENIA HOTELS & RESORTS INC. | May 13, 2025 | To approve an amendment to the 2015 Incentive Award Plan to increase the number of shares that may be issued thereunder. Compensation |
Board | For | FOR 19 funds |
AGAINST 11 funds |
| XOMA ROYALTY CORP. | May 28, 2025 | Approval of the Amended and Restated 2010 Long Term Incentive and Stock Award Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| ZAI LAB LTD | June 18, 2025 | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ZURN ELKAY | May 1, 2025 | Advisory vote to approve the compensation of Zurn Elkay's named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement. Say-on-Pay |
Board | Not determined | FOR 35 funds |
AGAINST 11 funds |
| 10X GENOMICS INC. | June 3, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 5 FOR, 26 AGAINST |
AGAINST 1 fund |
| ADVANTAGE SOLUTIONS INC. | May 28, 2025 | To approve, on a advisory (non-binding) basis, the compensation of Advantage Solution Inc.'s named executive officers. Say-on-Pay |
Board | For | Split 13 FOR, 1 AGAINST |
AGAINST 8 funds |
| ALPINE INCOME PROPERTY TRUST INC. | May 21, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | Split 7 FOR, 1 AGAINST |
AGAINST 8 funds |
| ALX ONCOLOGY HOLDINGS INC | June 11, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 1 FOR, 11 AGAINST |
AGAINST 8 funds |
| AMC NETWORKS INC | June 5, 2025 | Vote on Proposal to Approve the Company's Amended and Restated 2016 Employee Stock Plan Compensation |
Board | For | Split 7 FOR, 9 AGAINST |
AGAINST 8 funds |
| ANAPTYSBIO INC. | June 17, 2025 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. Say-on-Pay |
Board | For | Split 3 FOR, 22 AGAINST |
AGAINST 11 funds |
| ANGLO AMERICAN PLATINUM LIMITED | May 8, 2025 | ELECT LWAZI BAM OF SOCIAL, ETHICS AND TRANSFORMATION COMMITTEE Corporate Governance |
Board | For | Split 3 FOR, 8 AGAINST |
FOR 1 fund |
| ANGLO AMERICAN PLATINUM LIMITED | May 8, 2025 | RE-ELECT LWAZI BAM AS DIRECTOR Director Elections |
Board | For | Split 3 FOR, 8 AGAINST |
FOR 1 fund |
| ANGLO AMERICAN PLATINUM LIMITED | May 8, 2025 | RE-ELECT LWAZI BAM AS MEMBER OF THE AUDIT AND RISK COMMITTEE Corporate Governance |
Board | For | Split 3 FOR, 8 AGAINST |
FOR 1 fund |
| ANGLO AMERICAN PLATINUM LIMITED | May 8, 2025 | RE-ELECT THEVENDRIE BREWER AS DIRECTOR Director Elections |
Board | For | Split 3 FOR, 8 AGAINST |
FOR 1 fund |
| APPLIED THERAPEUTICS INC. | June 9, 2025 | To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials. Say-on-Pay |
Board | For | Split 15 FOR, 1 AGAINST |
FOR 9 funds |
| ARCHER AVIATION INC. | June 27, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 9 FOR, 22 AGAINST |
AGAINST 8 funds |
| ARISTA NETWORKS INC. | May 30, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 16 FOR, 53 AGAINST |
AGAINST 9 funds |
| AVIDITY BIOSCIENCES INC. | June 10, 2025 | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. Say-on-Pay |
Board | For | Split 9 FOR, 22 AGAINST |
AGAINST 11 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Hadi Partovi Director Elections |
Board | For | Split 12 FOR, 38 AGAINST |
FOR 24 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 13 FOR, 52 AGAINST |
FOR 24 funds |
| BANC OF CALIFORNIA INC. | May 7, 2025 | Approval, on an advisory and non-binding basis, of the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting (Say-on-Pay). Say-on-Pay |
Board | For | Split 6 FOR, 22 AGAINST |
FOR 13 funds |
| BAYCOM CORP | June 17, 2025 | An advisory (non-binding) vote on executive compensation. Say-on-Pay |
Board | For | Split 12 FOR, 1 AGAINST |
FOR 8 funds |
| BEIGENE LTD | May 21, 2025 | THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ...(due to space limits, see proxy material for full proposal). Capital Structure |
Board | For | Split 1 FOR, 2 AGAINST |
AGAINST 4 funds |
| BERRY GLOB | February 5, 2025 | To approve, on an advisory, non-binding basis, our executive compensation. Say-on-Pay |
Board | Not determined | Split 2 FOR, 31 AGAINST |
FOR 8 funds |
| BIOGEN INC. | June 17, 2025 | Say on Pay - To hold an advisory vote on executive compensation. Say-on-Pay |
Board | For | Split 44 FOR, 17 AGAINST |
AGAINST 26 funds |
| CARDLYTICS INC. | May 20, 2025 | Advisory vote to approve compensation of named executive officers. Say-on-Pay |
Board | For | Split 11 FOR, 1 AGAINST |
AGAINST 8 funds |
| CARGURUS INC. | June 4, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2024. Say-on-Pay |
Board | For | Split 4 FOR, 23 AGAINST |
FOR 11 funds |
| CARRIER GLOBAL CORP. | April 9, 2025 | Advisory Vote to Approve Named Executive Officer Compensation Say-on-Pay |
Board | For | Split 10 FOR, 44 AGAINST |
FOR 18 funds |
| CHIPOTLE MEXICAN GRILL INC. | June 11, 2025 | An advisory vote to approve the compensation of our executive officers as disclosed in the proxy statement ("say on pay"). Say-on-Pay |
Board | For | Split 13 FOR, 39 AGAINST |
AGAINST 17 funds |
| CLOUDFLARE INC. | June 5, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 40 FOR, 6 AGAINST |
FOR 4 funds |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Say-on-Pay, nonbinding advisory vote approving executive compensation. Say-on-Pay |
Board | For | Split 1 FOR, 8 AGAINST |
AGAINST 8 funds |
| CONFLUENT INC. | June 11, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | Split 25 FOR, 18 AGAINST |
FOR 4 funds |
| CORE SCIENTIFIC INC. | May 23, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement. Say-on-Pay |
Board | For | Split 1 FOR, 25 AGAINST |
AGAINST 9 funds |
| CORPAY INC. | June 11, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 7 FOR, 45 AGAINST |
AGAINST 15 funds |
| COURSERA INC. | May 20, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 7 FOR, 17 AGAINST |
AGAINST 8 funds |
| CRICUT INC. | May 28, 2025 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | Split 1 FOR, 15 AGAINST |
AGAINST 8 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay |
Board | For | Split 2 FOR, 19 AGAINST |
AGAINST 4 funds |
← Previous Page 4 of 5 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.